Extrapancreatic impacts of incretins also facilitate glucose regulation
If the batch numbers do not match across documents, or if the documents look like they were generated by different laboratories, that is a red flag
The effect was nominally significant for the GIPR/GLP-1R agonist (Beta: 0.35, 95%CI: 0.010.69, P = 0.046), while the associations for the GCGR/GLP-1R agonist (Beta: 0.28, 95%CI: 0.070.49, P = 7.97 10 3 ) and the GCGR/GIPR/GLP-1R agonist (Beta: 0.39, 95%CI: 0.110.66, P = 5.67 10 3 ) remained significant after multiple testing (Fig
Clinical applications reflect these differences
If gastrointestinal symptoms are interfering with daily life, your prescriber might pause or slow your dose escalation schedule
Dizziness, dark urine, fast heartbeat, or not peeing enough means you need more fluids and possibly medical help